Medicon Hellas

Medicon Hellas is a publicly listed company on the Athens Stock Exchange and a prominent diagnostics provider in Greece. The company focuses on the development, manufacturing, import, and distribution of a wide range of in vitro diagnostic (IVD) products. This includes instrumentation, reagents, molecular diagnostics, laboratory automation, and software solutions designed for clinical and research laboratories, as well as healthcare partners globally. Operating from a modern facility in Gerakas, Athens, Medicon Hellas supports its services through four technical offices across Greece. The company holds several international quality certifications, ensuring high standards in product quality and safety. Its diverse product portfolio features clinical chemistry, hematology, immunochemistry reagents, and molecular diagnostic kits, along with laboratory and medical software applications. Medicon serves a variety of customers, including hospitals, diagnostic laboratories, and primary care centers, and exports to over 50 countries. In addition to diagnostics, Medicon has ventured into cosmetics and personal care products, manufactured under strict quality controls. The company is committed to research and development, aiming to innovate diagnostic products and expand its laboratory network internationally, including plans for diagnostic centers in Africa.

• Employees 63
• Founded 1979